Leveraging Data from Tumor Animal Models to Translate Safe ErbB-Targeted Cell Therapies into the Clinic

Time: 9:30 am
day: Day Two


  • Characterizing the best available models for the TME
  • Utilizing strategies to expand to models with better translatability
  • Advancing beyond animal models with the first clinical data for LEU-001